India's Strides Arcolab Ltd
Bloomberg News and the local media said last month that Strides was in talks to sell Agila to Pfizer Inc . Pfizer is doing due diligence and a deal could be reached this quarter, Bloomberg said, citing sources that it did not identify.
"There is market talk the deal with Pfizer might get delayed or cancelled," said Narayan Patra, an analyst at Systematix.
See pharma sector's Q3 topline to grow 22%: Motilal Oswal
A spokesman at Strides declined to comment, while officials at Pfizer could not be immediately reached.
Shares in Striders were down 11.2 percent as of 0633 GMT.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
